Severe premature coronary artery disease with protease inhibitors

Lancet

Volumn 351, Issue 9112, 1998, Pages 1328-

  Henry, Keith ^a   Melroe, Holly ^b   Huebsch, Jacquelyn ^b   Hermundson, Jessica ^b   Levine, Claudia ^b   Swensen, Lyle ^b   Daley, Jack ^b  

^a REGIONS HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROTEINASE INHIBITOR;

ADULT; ARTICLE; CASE REPORT; CORONARY ARTERY DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIPODYSTROPHY; MALE; PRIORITY JOURNAL;

EID: 17144463863     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)79053-X     Document Type: Article

References (5)

1. 1 Cameron DW, Heath-Chiozzi M, Danner S, et al. Randomized placebo-controlled trial of ritonavir in advanced HIV-1 disease. Lancet 1998; 351: -49.
2. 2 National Institutes of Health. Cholesterol lowering in the patient with coronary artery disease: physician monograph-national cholesterol education program. September 1997 (NIH Publication 97-3794).
3. 3 Mann M, Piazza-Hepp T, Koller E, Gibert C. Abnormal fat distribution in AIDS patients following protease inhibitor therapy. FDA summary. In: Programs and Abstracts of the 5th National Conference on Retroviruses and Opportunistic Infections; Chicago, Illinois, Feb 1-5, 1998 (abstr 412).
4. 4 Miller K, Jones E, Yanovsky J, Shankar R, Feuerstein I, Falloon J. Visceral abdominal-fat associated with use of indinavir. Lancet 1998; 351: 871-75.
5. 5 Carr A, Samaras K, Burton S, Freund, J, Chisholm DJ, Cooper DA. A syndrome of peripheral lipodystrophy and insulin resistance due to HIV protease inhibitors. In: Programs and Abstracts of the 5th National Conference on Retroviruses and Opportunistic Infections; Chicago, Illinois: Feb 1-5, 1998 (abstr 410).